Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

被引:0
作者
Constance X. Zou
Jessica E. Becker
Adam T. Phillips
James M. Garritano
Harlan M. Krumholz
Jennifer E. Miller
Joseph S. Ross
机构
[1] Yale School of Medicine,Department of Psychiatry
[2] Massachusetts General Hospital,Division of Cardiovascular Medicine, Department of Internal Medicine
[3] McLean Hospital,Section of Cardiovascular Medicine, Department of Internal Medicine
[4] Harvard Medical School,Department of Health Policy and Management
[5] Beth Israel Deaconess Medical Center,Center for Outcomes Research and Evaluation
[6] Yale School of Medicine,Section of General Medicine, Department of Internal Medicine
[7] Yale School of Public Health,undefined
[8] Yale-New Haven Hospital,undefined
[9] Yale School of Medicine,undefined
来源
Trials | / 19卷
关键词
FDAAA; ClinicalTrials.gov; Clinical trial registration; Clinical trial results; Selective publication; Publication bias;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 156 条
  • [1] Dickersin K(2011)Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO JRSM 104 532-538
  • [2] Chalmers I(2012)Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis BMJ 344 d7292-2064
  • [3] Ross JS(2014)Fate of protocols submitted to a French national funding scheme: a cohort study PLOS One 9 e99561-260
  • [4] Tse T(2010)Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes JAMA 303 2058-1520
  • [5] Zarin DA(2015)Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012 BMJ Open 5 e009758-378
  • [6] Xu H(2013)Non-publication of large randomized clinical trials: cross sectional analysis BMJ 347 f6104-468
  • [7] Zhou L(2008)Selective publication of antidepressant trials and its influence on apparent efficacy N Engl J Med 358 252-1971
  • [8] Krumholz HM(2014)Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: a cross-sectional study JAMA Intern Med 174 1518-1600
  • [9] Decullier E(2016)Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers BMJ 352 i637-510
  • [10] Huot L(2008)Publication of clinical trials supporting successful new drug applications: a literature analysis PLOS Med 5 e191-2438